Related Experiment Video

Updated: Mar 17, 2026

Generation of Integration-free Human Induced Pluripotent Stem Cells Using Hair-derived Keratinocytes
08:36

Generation of Integration-free Human Induced Pluripotent Stem Cells Using Hair-derived Keratinocytes

Published on: August 20, 2015

12.1K

Generation of four induced pluripotent stem cell lines from Korean patients with Huntington's disease (IPBi001-A,

Miju Lee1, Yoon-Eun Kim1, Wonjue Choi1

  • 1Cell & Gene Therapy Research Team, iPS Bio, Inc., Seongnam-si, Gyeonggi-do, the Republic of Korea.

Stem Cell Research
|March 15, 2026
PubMed

Insights

Researchers generated human induced pluripotent stem cell (iPSC) lines from Korean Huntington's disease patients. These valuable iPSC lines are crucial for disease modeling and developing new therapies.

Area of Science:

  • Neuroscience
  • Stem Cell Biology
  • Genetics

Background:

  • Huntington's disease is a progressive neurodegenerative disorder.
  • Patient-derived induced pluripotent stem cells (iPSCs) offer a powerful tool for studying complex genetic diseases.
  • Establishing reliable disease models is critical for therapeutic development.

Purpose of the Study:

  • To generate and characterize induced pluripotent stem cell (iPSC) lines from Korean patients with Huntington's disease (HD).
  • To validate these iPSC lines as a valuable resource for future research in HD.
  • To assess the potential of these cells for drug discovery and treatment efficacy studies.

Main Methods:

  • Peripheral blood mononuclear cells (PBMCs) were collected from four Korean HD patients.
  • A non-integrating Sendai virus vector was used for reprogramming PBMCs into iPSCs.
  • Pluripotency was confirmed using immunocytochemistry and flow cytometry for specific markers (OCT4, NANOG, SSEA-4, TRA-1-60, TRA-1-81).
  • In vitro trilineage differentiation potential was assessed.
  • Karyotype stability and short tandem repeat (STR) profiling were performed to confirm genetic identity and absence of viral integration.

Main Results:

  • Successfully generated multiple iPSC lines from HD patient PBMCs.
  • Confirmed pluripotency and differentiation capacity of the generated iPSC lines.
  • Verified normal karyotypes and patient-specific STR profiles, ensuring genetic integrity.
  • Demonstrated complete clearance of the Sendai virus post-reprogramming.

Conclusions:

  • Patient-derived iPSCs from Korean Huntington's disease individuals were successfully created and validated.
  • These iPSC lines represent a significant resource for modeling Huntington's disease.
  • The established cell lines are suitable for preclinical research, including drug screening and therapeutic evaluation.

More Related Videos

Generation of Induced Pluripotent Stem Cells from Muscular Dystrophy Patients: Efficient Integration-free Reprogramming of Urine Derived Cells09:11

Generation of Induced Pluripotent Stem Cells from Muscular Dystrophy Patients: Efficient Integration-free Reprogramming of Urine Derived Cells

Published on: January 28, 2015

11.7K
Reprogramming Human Somatic Cells into Induced Pluripotent Stem Cells iPSCs Using Retroviral Vector with GFP08:25

Reprogramming Human Somatic Cells into Induced Pluripotent Stem Cells iPSCs Using Retroviral Vector with GFP

Published on: April 3, 2012

21.2K

Related Concept Videos

EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.5K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
6.0K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.4K
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.3K